Source Health Economics

We are an independent consultancy specialising in evidence generation, health economics, and communication.
Based in London and Oxford, UK.

[Source Health Economics @source_he]

We are actively working with companies to help them understand key changes to methods and processes arising from the #NICE methods update and any implications for #HTA submissions. For more information, please email us at [email protected] #HEOR #Training #Learning

[Economics of Population Health Research Centre @EPH_Oxford]

HERC SHORT COURSES AUTUMN 2022

HERC offers a varied programme of short courses designed for health economists, health care professionals, academic researchers, students and clinical investigators at different stages in their careers. 1/4
#healtheconomics

https://t.co/JY13MPoBbQ

[peter llewellyn @networkpharma]

Interested in learning more about careers in or around #medcomms? #MedicalWriting? #MedicalEditing? #AccountManagement? Meet us at Heathrow on 19 September. Make a day of it. We'll make it worth your while. We're going to change lives. Maybe yours. See https://t.co/9qZmNjmomH

[peter llewellyn @networkpharma]

one for the #MedComms wannabes here

[peter llewellyn @networkpharma]

All these leading #MedComms employers will be at Heathrow on 19 September and there are still more coming - help spread the word and please join us. Details are being kept bang up-to-date at https://t.co/9qZmNjmomH

[peter llewellyn @networkpharma]

Kudos to @AMICULUM_global, @LanglandLife and @OxPharmaGenesis for leading the way on #MedComms Day 2022 - see details at https://t.co/I4VuXNNRaC including the Illuminate event at 12.00 BST, a virtual event for experienced and aspiring medcomms professionals alike. Enjoy

[peter llewellyn @networkpharma]

I still can't find my #MedComms hats, but I'm enjoying my morning cuppa out of my #MedComms cup. So, cheers - wishing a happy #MedComms Day 2022 to everyone, everywhere! Enjoy your day, today, 22 June, and every day. Keep up the good work.

[peter llewellyn @networkpharma]

Updated careers guide for wannabe #MedComms specialists now freely available. Thanks to all who contributed and supported this valuable careers guide, Evidence generation and communication: a guide to getting started in HEOR/market access medical writing https://t.co/fXnZpCrNEx

[Source Health Economics @source_he]

In this blog, we take at look at Patient Participation Groups, an important voice for patients receiving healthcare in the UK #PPG #MedComms
https://t.co/ttXm94iXj2

[Source Health Economics @source_he]

We are actively working with companies to help them understand key changes to processes arising from the NICE methods update and launch of the Innovative Medicines Fund (IMF), and the implications for HTA submissions. #NICE #HEOR #IMF https://t.co/GzhMYwLCbj

[peter llewellyn @networkpharma]

We've a bigger than usual crowd gathering for this next #MedComms webinar on Wednesday 8 June. It should be of interest to everyone and everyone's welcome >> Writing for Patients: Who, What, Where, When, Why and How? with the team from @IQVIA_UK https://t.co/LUCb1ZTeCo

[@IAmSciComm - On a Break! @iamscicomm]

A thread about using color as a design tool in science presentations. Color is a great tool to separate different categories of information, to highlight information, or to establish an emotional tone. 🧵1/20

[Source Health Economics @source_he]

The latest NICE methods update may impact the evidence hierarchy in GVDs. If you would like to learn more about evidence selection when communicating the value of your product, please contact us at [email protected]
#NICE #HEOR #SourceHealthEconomics
https://t.co/zSOpVcoYCt

[@IAmSciComm - On a Break! @iamscicomm]

A thread about using fonts/typography in presentations. Decisions about text matter. Just as you can speak the same word in many ways, the way you write text can affect communication, emotion, and attitude. 🧵1/19

[EuHEA @EuHEA]

Estimating Health Inequality Aversion and Equity Weights - presented by Matthew Robson @UniOfYork tomorrow in our online seminar at 2:30pm. Join us! #HealthEconomics

Register here👉 https://t.co/10n8aM3XvA
@Unibo @UniOslo_HELED

[peter llewellyn @networkpharma]

Here we go everyone, and kudos to @AMICULUM_global , @LanglandLife and @OxPharmaGenesis for leading the way this year. Make a diary note now - 22 June is #MedComms Day 2022

[Source Health Economics @source_he]

In todays blog, we summarise the problems encountered when searching for relevant conference abstracts, and outline suggested approaches and their subsequent impact https://t.co/u1r6anGDym

#systematicreview #conferenceabstract #embase

[Source Health Economics @source_he]

Our new blog post looks at the challenges of antimicrobial resistance, how NICE are leading the way by testing a new process for evaluating novel treatments, and the challenges identified in two pilot appraisals.

#NICE #antimicrobialresistance
https://t.co/MrKanweK2c

[Source Health Economics @source_he]

We are actively working with companies to help them understand key changes to methods and processes arising from the #NICE methods update and any implications for #HTA submissions. For more information, please email us at [email protected] #HEOR #Training #Learning

[Cochrane @cochranecollab]

💻 Register for this FREE #cochranelearninglive webinar on 'Rapid evidence synthesis for #COVID19 research' on 14 June.
➡️ https://t.co/yhvGWUTSFX Everyone welcome!
#RapidReview @cochranetrain @cochranemthds

[Source Health Economics @source_he]

Our new blog post looks at the challenges of antimicrobial resistance, how NICE are leading the way by testing a new process for evaluating novel treatments, and the challenges identified in two pilot appraisals.

#NICE #antimicrobialresistance
https://t.co/MrKanweK2c